Postoperative circulating tumor cells: An early predictor of extrahepatic metastases in patients with hepatocellular carcinoma undergoing curative surgical resection

被引:23
|
作者
Sun, Yun-Fan [1 ,2 ]
Wang, Peng-Xiang [1 ,2 ]
Cheng, Jian-Wen [1 ,2 ]
Gong, Zi-Jun [1 ,2 ]
Huang, Ao [1 ,2 ]
Zhou, Kai-Qian [1 ,2 ]
Hu, Bo [1 ,2 ]
Gao, Ping-Ting [1 ,2 ]
Cao, Ya [3 ,4 ]
Qiu, Shuang-Jian [1 ,2 ]
Zhou, Jian [1 ,2 ,5 ]
Fan, Jia [1 ,2 ,5 ]
Guo, Wei [6 ]
Yang, Xin-Rong [1 ,2 ]
机构
[1] Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Dept Liver Surg & Transplantat, Shanghai, Peoples R China
[2] Minist Educ, Key Lab Carcinogenesis & Canc Invas, Shanghai, Peoples R China
[3] Cent South Univ, Xiangya Sch Med, Canc Res Inst, Changsha, Peoples R China
[4] Minist Educ, Key Lab Carcinogenesis & Canc Invas, Changsha, Peoples R China
[5] Fudan Univ, Inst Biomed Sci, Shanghai, Peoples R China
[6] Fudan Univ, Zhongshan Hosp, Dept Lab Med, 180 Fenglin Rd, Shanghai 200032, Peoples R China
基金
中国国家自然科学基金;
关键词
circulating tumor cells (CTCs); early predictor; extrahepatic metastases; hepatocellular carcinoma (HCC); postoperative; BREAST-CANCER PATIENTS; ALPHA-FETOPROTEIN; CLINICAL-SIGNIFICANCE; RECURRENCE; SURVIVAL; SORAFENIB; PROGNOSIS; MODEL;
D O I
10.1002/cncy.22304
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Postoperative extrahepatic metastases (EHM) contribute to a grim outcome in patients with hepatocellular carcinoma (HCC) who are undergoing curative surgical resection. The current study investigated the clinical value of circulating tumor cells (CTCs) in predicting EHM after curative surgery. Methods A total of 197 patients with HCC who were undergoing curative surgical resection were assigned to a retrospective training cohort (144 patients) or a prospective validation cohort (53 patients). The CELLSEARCH system was used for the detection of CTCs prior to surgical resection and 1 month thereafter. The cutoff value of CTCs was estimated using receiver operating characteristic analysis. Bonferroni correction was applied for multiple testing in a Cox proportional hazards regression model. Results In the training cohort, EHM was found to be associated with a higher postoperative CTC burden compared with no EHM (mean: 4.33 vs 0.52; P < .001). Receiver operating characteristic analysis demonstrated a postoperative CTC count >= 3 as the optimal cutoff value for the prediction of EHM. Patients with a postoperative CTC count >= 3 experienced a higher EHM risk (56.3% vs 5.5%) and a shorter median overall survival (31.25 months vs not reached) (all P < .001). The prognostic significance of a postoperative CTC count >= 3 also applied to patient subgroups with a low EHM risk, such as those with an alpha-fetoprotein level <= 400 ng/mL, absence of vascular invasion, well differentiation, and early tumor stage, and its predictive value was retained in patients with a continuous normal alpha-fetoprotein level during postoperative follow-up (all P < .05). The results were confirmed in the validation cohort. Conclusions A postoperative CTC count >= 3 appears to be a surrogate marker for the prediction of EHM after curative surgical resection of HCC. More careful surveillance should be recommended to patients with a high CTC load to ensure the greater possibility of early interventions for postoperative EHM.
引用
收藏
页码:733 / 745
页数:13
相关论文
共 50 条
  • [21] Enumeration and Characterization of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
    Espejo-Cruz, Maria L.
    Gonzalez-Rubio, Sandra
    Espejo, Juan J. J.
    Zamora-Olaya, Javier M. M.
    Alejandre-Altamirano, Rafael M. M.
    Prieto-Torre, Maria
    Linares, Clara I. I.
    Guerrero-Misas, Marta
    Barrera-Baena, Pilar
    Poyato-Gonzalez, Antonio
    Sanchez-Frias, Marina
    Ayllon, Maria D.
    Rodriguez-Peralvarez, Manuel L. L.
    de la Mata, Manuel
    Ferrin, Gustavo
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [22] Circulating Tumor DNA in Patients Undergoing Liver Transplant for Hepatocellular Carcinoma, Cholangiocarcinoma, and Colorectal Liver Metastases
    Hong, Hanna
    Wehrle, Chase J.
    Fares, Sami
    Stitzel, Henry
    Estfan, Bassam
    Kamath, Suneel
    Krishnamurthi, Smitha
    Ma, Wen Wee
    Khalil, Mazhar
    Pita, Alejandro
    Schlegel, Andrea
    Kim, Jaekeun
    Hashimoto, Koji
    Walsh, R. Matthew
    Kwon, David C. H.
    Aucejo, Federico
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S185 - S186
  • [23] Utilization of personalized tumor-specific methylation haplotypes of circulating DNA to monitor minimal residual disease in patients with hepatocellular carcinoma undergoing curative resection
    Yang, Xin-Rong
    Guo, De-Zhen
    Zhang, Shi-Yu
    Xu, Min-Jie
    Chen, Hua
    Ma, Cheng-Cheng
    Fu, Rui-Qing
    Su, Ming-Yang
    He, Qi-Ye
    Zhang, Yun-Zhi
    Su, Zhi-Xi
    Liu, Rui
    Fan, Jia
    Zhou, Jian
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [24] The value of peritoneal cytology as a preoperative predictor in patients with gastric carcinoma undergoing a curative resection
    Bentrem, D
    Wilton, A
    Mazumdar, M
    Brennan, M
    Coit, D
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2005, 12 (05) : 347 - 353
  • [25] The Value of Peritoneal Cytology as a Preoperative Predictor in Patients With Gastric Carcinoma Undergoing a Curative Resection
    David Bentrem
    Andrew Wilton
    Madhu Mazumdar
    Murray Brennan
    Daniel Coit
    [J]. Annals of Surgical Oncology, 2005, 12 : 347 - 353
  • [26] Circulating Tumor Cells are an Independent Predictor of Shorter Survival in Patients Undergoing Resection for Pancreatic and Periampullary Adenocarcinoma
    Hugenschmidt, Harald
    Labori, Knut Jorgen
    Brunborg, Cathrine
    Verbeke, Caroline Sophie
    Seeberg, Lars Thomas
    Schirmer, Cecilie Bendigtsen
    Renolen, Anne
    Borgen, Elin Faye
    Naume, Bjorn
    Wiedswang, Gro
    [J]. ANNALS OF SURGERY, 2020, 271 (03) : 549 - 558
  • [27] Central, But Not Peripheral, Circulating Tumor Cells are Prognostic in Patients Undergoing Resection of Colorectal Cancer Liver Metastases
    Ashton A. Connor
    Kate McNamara
    Eisar Al-Sukhni
    Jacob Diskin
    David Chan
    Colleen Ash
    Lori E. Lowes
    Alison L. Allan
    George Zogopoulos
    Carol-Anne Moulton
    Steven Gallinger
    [J]. Annals of Surgical Oncology, 2016, 23 : 2168 - 2175
  • [28] Central, But Not Peripheral, Circulating Tumor Cells are Prognostic in Patients Undergoing Resection of Colorectal Cancer Liver Metastases
    Connor, Ashton A.
    McNamara, Kate
    Al-Sukhni, Eisar
    Diskin, Jacob
    Chan, David
    Ash, Colleen
    Lowes, Lori E.
    Allan, Alison L.
    Zogopoulos, George
    Moulton, Carol-Anne
    Gallinger, Steven
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (07) : 2168 - 2175
  • [29] Circulating Tumor Cells Undergoing EMT Provide a Metric for Diagnosis and Prognosis of Patients with Hepatocellular Carcinoma
    Qi, Lu-Nan
    Xiang, Bang-De
    Wu, Fei-Xiang
    Ye, Jia-Zhou
    Zhong, Jian-Hong
    Wang, Yan-Yan
    Chen, Yuan-Yuan
    Chen, Zu-Shun
    Ma, Liang
    Chen, Jie
    Gong, Wen-Feng
    Han, Ze-Guang
    Lu, Yan
    Shang, Jin-Jie
    Li, Le-Qun
    [J]. CANCER RESEARCH, 2018, 78 (16) : 4731 - 4744
  • [30] Correlation Between Postoperative Early Recurrence of Hepatocellular Carcinoma and Mesenchymal Circulating Tumor Cells in Peripheral Blood
    Zhong Wang
    Lei Luo
    Yuan Cheng
    Guolin He
    Bangjian Peng
    Yi Gao
    Ze-sheng Jiang
    MingXin Pan
    [J]. Journal of Gastrointestinal Surgery, 2018, 22 : 633 - 639